Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Chronic Back Pain Clinical Trials

A listing of Chronic Back Pain medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

SUMMIT Phase 3 Program The SUMMIT Phase 3 program for NKTR-181 includes two enriched-enrollment, randomized withdrawal (EERW) efficacy and safety studies and a 52-week long-term safety study (SUMMIT-LTS). Enrollment has begun in the first Phase 3 efficacy study (SUMMIT-07) which will evaluate NKTR-181 versus placebo in opioid-naïve patients with chronic ...

Phase

This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of chronic low back pain. If you qualify for participation in this study, your participation would last approximately 25 weeks and you would be required to make about 20 office visits to ...

Phase

Low back pain study for people with chronic low back pain ages 18 and older. The study medication is tanezumab, a subcutaneous injection given every 8 weeks designed to relieve pain. Tanezumab will be compared to Tramadol, a drug that is approved to treat moderate to severe pain, and a ...

Phase

The purpose of this research study is to compare the effects of the investigational study drug, tanezumab, with another drug called tramadol (also called Tradorec XL®, prolonged release tablets) and a placebo to find out which is better for treating chronic low back pain. Tramadol is a drug that is ...

Phase

To determine the analgesic efficacy of XXXXX (BID) in patients with moderate-to-severe chronic low back pain requiring opioid analgesia for an extended period of time.

Phase

Phase III study in patients with a Recent History of Moderate to Severe Chronic Low Back Pain currently treated with Opioids.

Phase

This study will be a Phase III, placebo-controlled, multicenter study with an enriched-enrollment withdrawal design to evaluate the efficacy and safety of CAM2038 in opioid-experienced subjects with moderate to severe CLBP that requires continuous, around-the-clock (ATC) opioid treatment. The study will comprise 5 phases: a Screening Phase (up to 2 ...

Phase

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.

Phase

A Prospective Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain

This is a prospective, multicenter, randomized, double-blind, placebo-controlled Phase 3 study designed to evaluate the safety and efficacy of Mesoblast's rexlemestrocel-L alone or combined with hyaluronic acid (HA) in subjects with chronic low back pain (> 6 months) associated with moderate radiographic degenerative changes of a disc

Phase

Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain

This is a randomized, double-blind, active-controlled, multicenter, parallel-group Phase 3 study of the safety and efficacy of tanezumab when administered by SC injection for up to 56 weeks in subjects with chronic low back pain. Approximately 390 subjects will be randomized to 1 of 3 treatment groups in a 1:1:1 ...

Phase